IMAX Discovery
IMAX Discovery is a privately held, research-driven biotechnology company founded in 2007 in Konstanz, Germany, with 101-250 employees. Its specific therapeutic focus, technology platform, pipeline, and business model are not disclosed in available public sources.
- Company typePrivate
- Founded2007
- HeadquartersKonstanz, Germany
- Headcount101–250
- GTM typeB2B
- OfferingServices
What IMAX Discovery does
IMAX Discovery is a privately held, for-profit biotechnology company classified as research-driven, headquartered in Konstanz, Germany. Founded in 2007, the company has operated for over 17 years and currently maintains a workforce of 101-250 employees under the leadership of CEO and Managing Director Alessandro Sidoli. Its corporate website (imaxdiscovery.com) currently presents only a loading/verification page, providing no substantive description of therapeutic focus, modalities, or pipeline assets.
No core products, technology platforms, target indications, or service offerings are disclosed in the available data. The company description of "research-driven biotechnology" suggests an emphasis on early-stage discovery work, but the specific scientific domain (small molecules, biologics, cell/gene therapy, diagnostics, CRO services) is not specified in the public material reviewed. There is no evidence of clinical-stage assets, commercial products, or proprietary platform technology in the available source material.
The business model is similarly opaque: no pricing structure, customer segments, licensing arrangements, grant funding, or revenue mechanics are disclosed. Given the 101-250 headcount, German operating location, and 2007 founding, the company likely operates either as a preclinical/early-clinical discovery entity reliant on grants and partnership revenue, or as a contract research organization — but neither hypothesis can be confirmed from available evidence. A comprehensive diligence effort would require direct management outreach to clarify pipeline, business model, and capital structure.
IMAX Discovery firmographics
Firmographics- Name
- IMAX Discovery
- Website
- https://imaxdiscovery.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- IMAX Discovery is a privately held, research-driven biotechnology company founded in 2007 in Konstanz, Germany, with 101-250 employees. Its specific therapeutic focus, technology platform, pipeline, and business model are not disclosed in available public sources.
- Ownership category
- akta.pro rank
Where IMAX Discovery is headquartered
LocationHeadquarters
- HQ city
- Konstanz
- HQ country
- Germany
- HQ region
- Europe
Markets served
IMAX Discovery business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
IMAX Discovery product offering
Product offeringCore offering
IMAX Discovery is a research-driven biotechnology company based in Konstanz, Germany, founded in 2007. The company conducts biotechnology research activities for life sciences and pharmaceutical applications. Specific product/service details are not publicly disclosed on the company's website, which displays a verification page rather than substantive content.
Differentiator
Problem solved
Functional benefit
Products and services
- Biotechnology Research Services
Companies that use IMAX Discovery
Customer profileIdeal customer profiles1 record
IMAX Discovery technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
IMAX Discovery partnerships and signals
Strategic signalRecent moves1 record
IMAX Discovery competitors and assessment
Company assessmentMarket position
Weaknesses4 records
Competitive moat3 records
Customer concentration
IMAX Discovery social profiles
Digital presenceIMAX Discovery financial estimates
Financial estimateRevenue estimate
Valuation estimate
IMAX Discovery leadership team
Management profileNumber of profiles
Profiles1 record
IMAX Discovery funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IMAX Discovery M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IMAX Discovery
What does IMAX Discovery do?
IMAX Discovery is a research-driven biotechnology company based in Konstanz, Germany, founded in 2007. The company conducts biotechnology research activities for life sciences and pharmaceutical applications. Specific product/service details are not publicly disclosed on the company's website, which displays a verification page rather than substantive content.
Is IMAX Discovery a public or private company?
IMAX Discovery is a private company. It is classified as unknown and is currently operating.
When was IMAX Discovery founded?
IMAX Discovery was founded in 2007. It employs 101 to 250 people.
Where is IMAX Discovery based?
IMAX Discovery is headquartered in Konstanz, Germany, in the Europe region.
Does IMAX Discovery have an API?
No public API is recorded for IMAX Discovery.